| 查看: 2148 | 回复: 6 | |||
[交流]
《Canadian Journal of Gastroenterology and Hepatology》(影响因子2.307)征稿启示 已有3人参与
|
|
《Canadian Journal of Gastroenterology and Hepatology》征稿启事 此期刊现有专栏征稿，“Immunometabolic Disorders and Liver Diseases”，欢迎各位感兴趣的老师，同学投稿。链接：https://www.hindawi.com/journals/cjgh/si/518262/cfp/ Immunometabolic Disorders and Liver Diseases Call for Papers The prevalence of metabolic liver diseases (MLD) is increasing dramatically in both developing and industrialized countries, causing a big burden to society. MLD is largely attributed to unhealthy lifestyle choices, including caloric-over-consumption, lack of exercise, and circadian rhythm disruption. Notably, unresolved metabolic disorders, accompanied by chronic inflammation, will cause liver damage and fibrosis and eventually promote hepatocellular carcinoma. Therefore, elucidation of mechanisms underlying MLD progression together with development of efficient therapeutic strategies against it is essential and urgent. In recent years, a noticeable number of findings have unveiled the modulation of metabolic homeostasis by the immune system. In the setting of MLD, metabolic stress (e.g., liver steatosis, hypoxia) predisposes liver cells to injury caused by dysregulated inflammatory responses and aberrant cytokine production, which in turn exacerbates metabolic comorbidities. Accordingly, intrahepatic immune cells as well as hepatic inflammatory pathways are promising targets for strategies against MLD. This special issue is to promote the researches that investigate the interplay between inflammatory/immune pathways and metabolic liver diseases, which will provide novel insights into this emerging field. Research articles and reviews relating to liver metabolism, inflammation, and immunity are especially encouraged to be submitted to this special issue. Potential topics include but are not limited to the following: Hepatic glucose/lipid disorders and immune response Alcoholic liver disease and immune responses Nonalcoholic fatty liver disease (NAFLD) and immune responses MLD and liver inflammation MLD and liver injury/fibrosis Epidemiological studies of MLD and immune system Clinical studies involved in MLD and immune responses Pharmaceutical investigation of MLD treatment Authors can submit their manuscripts through the Manuscript Tracking System at https://mts.hindawi.com/submit/journals/cjgh/hepatology/mld/. Submission Deadline Friday, 27 October 2017 Publication Date March 2018 Papers are published upon acceptance, regardless of the Special Issue publication date. Lead Guest Editor Hong Shen, University of Michigan, Ann Arbor, USA Guest Editors Mark J. Canet, University of Michigan, Ann Arbor, USA Liang Sheng, Nanjing Medical University, Nanjing, China Feihua Wu, China Pharmaceutical University, Nanjing, China Kae W. Cho, Soonchunhyang University, Asan, Republic of Korea Qilin Gu, Houston Methodist Research Institute, Houston, USA |
回复此楼» 猜你喜欢
有多少人是今天查系统知道结果的？
已经有14人回复
-
范进中举一文的中心思想
已经有10人回复
-
我不理解！
已经有13人回复
-
2026年的国家社科基金项目通讯评审的新规则与新动向、新挑战
已经有9人回复
-
2026国自然函评费到账
已经有25人回复
-
2026年8月25日国自然放榜前突然收到列入评审专家邮件，有关系吗？
已经有28人回复
-
能否退出参与的面上项目解除限项
已经有26人回复
-
出来了
已经有9人回复
-
只有每年这种时候来逛逛小木虫
已经有28人回复
-
哪位高人中了，把查询到的截图贴出来让我看看，让我长长见识
已经有5人回复
 |
2楼2017-08-19 09:06:13
 |
3楼2017-08-19 10:39:00
|
|
4楼2017-08-19 18:15:32
|
|
5楼2017-08-21 07:33:16
|
|
6楼2017-08-21 09:15:28
|
|
7楼2017-08-22 11:19:24
投票:
